elpline is the only one of its kind in Europe and there is a strong commitment on the part of all parties involved in particular The Welsh School of Pharmacy, Parkinson's Disease Society and WMIC to sustain, beyond the pilot study, and to expand the delivery of reliable, clear and easily accessible information to all patients with Parkinson's Disease and their carers."
Parkinson's Disease is one of the commonest causes of disability in older people, with more than 120,000 patients in the United Kingdom and at least 10,000-12,000 new cases diagnosed annually. The number of patients with Parkinson's Disease in Wales is estimated at a minimum of 6,000. Prevalence and incidence will both increase with the ageing population and the reduction in competing causes of mortality such as, stroke and coronary heart disease.
The dedicated freephone number for patients and carers is 0800 3894436, available from 8.30am to 5.00pm Monday to Friday. The number for healthcare professionals is (029) 2074 4861. Enquiries from outside Wales during the pilot period will be referred to local facilities.
Page: 1 2 Related medicine news :1
Contact: Dr. Sam Salek
. Rasagiline reduces disability for patients with advanced Parkinsons disease2
. LRRK2 gene mutation causes Parkinsons disease in several families3
. Physical activity linked to protection from Parkinsons disease4
. PCBs, fungicide open brain cells to Parkinsons assault5
. New study in NEJM suggests levodopa may slow progression of Parkinsons disease6
. Two-fisted assault on dopamine transport system may be foundation of Parkinsons disease7
. Antibiotic rifampicin shows promise for fighting Parkinsons disease in lab tests8
. University seeks recruits for Parkinsons Disease study9
. Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinsons to pain10
. Exercising limbs protects brain cells affected by Parkinsons, study in rodents shows11
. Parkinsons patients get bilateral benefits with unilateral brain stim